Amongst the possible targets, the covalent inhibition of the cancer relevant selenoenzyme thioredoxin reductase 1 (TXNRD1) [40] and of membrane transporters of water and glycerol (aquaglyceroporins, AQPs) [41] by cyclometalated gold(III) compounds have been recently reported. This evidence concerns the gene TXNRD1 and cancer.